STUDIES ON PREPARATION OF INACTIVATED VACCINES FROM CELL CULTURES OF MINK ENTERITIS VIRUS (MEV) AND THEIR IMMUNITY

In this paper, superhigh reproductive rate strains of MEV with titre more than HA8192* or TCID50 log9.7 10 have been achieved both by cultivation in cell lines with different susceptibility to MEV and by isolating and identifying in field by the author. The systematic tests proved that S18 and L12 strains of MEV are the best strains for vaccine preparation. In this study, the best means for the tissue cultivation of MEV and the most advanced technological process for the production and detection of serum-free cell-cultured MEV fluids with super-high HA titre in batches in large quantities have been established for the first time. Optimum conditions for MEV inactivation were determined, and safe and effective inactivated vaccines with mineral oil or A1(OH)3 gel adjuvant were successfully prepared with serum-free cell-cultured MEV fluids. Both vaccines with different adjuvants can be manufactured in batches in large quantities and have been widely used all over China since 1986. The change laws of the imm     

Assembly of a series of malarial glycosylphosphatidylinositol anchor oligosaccharides

We report an efficient and convergent synthesis of a series of oligosaccharides comprised of the malaria GPI glycan (2a), a promising anti-malaria vaccine candidate currently in preclinical trials and several related oligosaccharide sequences (3-8) that are possible biosynthetic precursors of the malarial GPI. A flexible synthetic strategy is disclosed that relies on a late-stage coupling between oligomannosides of varying length and pseudo-disaccharide glycosyl acceptor 11 to readily access various malarial GPI structures. Phosphorylation was accomplished by mild and efficient H-phosphonate chemistry before the final deprotection was carried out by using sodium in ammonia. The direct connection of a thiol group via a phosphate diester linkage to the inositol moiety provides a handle for easy conjugation of the GPI glycan to carrier proteins, immobilization on carbohydrate microarrays and photo-affinity labels identification. These synthetic oligosaccharides will serve as molecular probes.     

Total Syntheses of Conjugation-Ready Repeating Units of Acinetobacter baumannii AB5075 for Glycoconjugate Vaccine Development

Acinetobacter baumannii is an opportunistic pathogen that causes serious nosocomial infections. One of the multidrug-resistant strains, AB5075, can result in bacteremia, pneumonia and wound infections associated with high morbidity and mortality. The structurally unique glycans on the surface of these bacteria are attractive targets for the development of glycoconjugate vaccines. Here, we report the first total synthesis of the densely functionalized trisaccharide repeating unit of A. baumannii AB5075 as well as two analogues. The construction of 1,2-cis linkages between the rare sugars relies on a double-serial inversion strategy. The judicious selection of building blocks and reaction conditions allowed for stereoselective glycosylations, the installation of acetamido groups and the (S)-3-hydroxybutanoyl chain.     

Synthesis of the Branched Trisaccharide L‐Glycero‐α‐D‐manno‐heptopyranosyl‐(1 → 3)‐ [β‐D‐glucopyranosyl‐(1 → 4)]‐L‐glycero‐α‐D‐manno‐heptopyranose,Protected to Allow Flexible Access to Neisseria and Haemophilus LPS Inner Core Structures

Abstract

An efficient synthesis of the protected branched trisaccharide (2′S,3′S)‐(7‐O‐benzyl‐6‐O‐chloroacetyl‐3,4‐O‐(2′,3′‐dimethoxybutane‐2′,3′‐diyl)‐2‐O‐p‐methoxybenzyl‐L‐glycero‐α‐D‐manno‐heptopyranosyl)‐(1 → 3)‐[(2,3,4,6‐tetra‐O‐benzoyl‐β‐D‐glucopyranosyl)‐(1 → 4)]‐7‐O‐acetyl‐1,6‐anhydro‐2‐O‐benzyl‐L‐glycero‐β‐D‐manno‐heptopyranose, which is a key intermediate in the synthesis of inner core structures of Haemophilus and Neisseria LPSs, is described. The heptoses were formed by Grignard reactions using a benzyloxymethyl chloride or a commercial vinyl reagent. The anhydro bridge was formed by treatment of a 6‐OH methyl α‐heptoside precursor with FeCl₃. The protecting group pattern allows modifications at the 2‐, 3‐, 4‐, and 6‐positions of the second heptose moiety and also, after acetolysis of the anhydro bridge, elongation at the reducing end, all known alterations found in the bacterial LPSs.     

Block Synthesis of Streptococcus pneumoniae Type 14 Capsular Polysaccharide Structures*

Synthesis of a thioglycoside tetrasaccharide block, β‐D‐Galp‐(1→4)‐β‐DGlcp‐(1→6)‐[β‐D‐Galp‐(1→4)]‐β‐D‐GlcNPhthp‐(1→SEt, corresponding to the repeating unit of Streptococcus pneumoniae serotype 14 CPS is described. Coupling of this block with a spacer followed by removal of an isopropylidene acetal yielded an acceptor, which was elongated with the donor block to give a protected dimer of the repeating unit. Iteration of this methodology yielded the trimer. Deprotection then produced an octa and a dodecasaccharide derivative ready for conjugation to proteins to afford immunoactive glycoconjugates.     

A Practical One‐Pot Synthesis of New S‐Glycosyl Amino Acid Building Blocks for Combinatorial Neoglycopeptide Synthesis

S‐Glycosyl L‐aspartic acid building blocks were synthesized starting from 1‐thiosugars by reaction with 5‐aminopentanol and suitably protected L‐aspartic acid pentafluorophenyl ester in a one‐pot procedure under Mitsunobu conditions using 1,1′‐azodicarbonyl dipiperidine and trimethyl phosphine. The method allowed for the preparation of S‐glycosyl amino acid building blocks in one step without protection of the amino function for the Mitsunobu condensation. Alternatively, the title compounds were prepared by a stepwise approach via 5‐aminopentyl 1‐thioglycosides.     

Synthesis of Cryptococcus neoformans Capsular Polysaccharide Structures. Part V: Construction of Glucuronic Acid‐Containing Thioglycoside Donor Blocks

Abstract

Glucuronic acid‐containing di‐ and trisaccharide thioglycoside building blocks, ethyl (benzyl 2,3,4‐tri‐O‐benzyl‐β‐D‐glucopyranosyluronate)‐(1 → 2)‐3‐O‐allyl‐4,6‐di‐O‐benzyl‐1‐thio‐α‐D‐mannopyranoside, ethyl (benzyl 2,3,4‐tri‐O‐benzyl‐β‐D‐glucopyranosyluronate)‐(1 → 2)‐6‐O‐acetyl‐3‐O‐allyl‐4‐O‐benzyl‐1‐thio‐α‐D‐mannopyranoside and ethyl (2,3,4‐tri‐O‐benzyl‐β‐D‐xylopyranosyl)‐(1 → 4)‐[(benzyl 2,3,4‐tri‐O‐benzyl‐β‐D‐glucopyranosyluronate)‐(1 → 2)]‐3‐O‐allyl‐6‐O‐benzyl‐1‐thio‐α‐D‐mannopyranoside, corresponding to repetitive structures in the capsular polysaccharide (CPS) of Cryptococcus neoformans, have been synthesized. The blocks contain an orthogonal allyl group in the 3‐position of the mannose residue to allow formation of the (1 → 3)‐linked mannan backbone of the CPS and benzyl ethers as persistent protecting groups to facilitate access to acetylated target structures. The glucuronic acid moiety was introduced using an acetylated trichloroacetimidate donor and the xylose residue employing the benzoylated bromo sugar to ensure β‐selectivity in the couplings. Exchange to benzyl protecting groups was then performed at the di‐ or trisaccharide level. Assembly of suitable blocks employing DMTST as promoter in diethyl ether then afforded, in high yield and with stereoselectivity, a protected pentasaccharide corresponding to a C. neoformans serotype D CPS structure.     

Fully Synthetic Self‐Adjuvanting Thioether‐Conjugated Glycopeptide?Lipopeptide Antitumor Vaccines for the Induction of Complement‐Dependent Cytotoxicity against Tumor Cells

Glycopeptides of tumor‐associated mucin MUC1 are promising target structures for the development of antitumor vaccines. Because these endogenous structures were weakly immunogenic, they were coupled to immune‐response‐stimulating T‐cell epitopes and the Pam₃Cys lipopeptide to induce strong immune responses in mice. A new thioether‐ligation method for the synthesis of two‐ and three‐component vaccines that contain MUC1 glycopeptides as the B‐cell epitopes, a T‐cell epitope peptide, and the Pam₃CSK₄ lipopeptide is described. The resulting fully synthetic vaccines were used for the vaccination of mice, either in a liposome with Freund′s adjuvant or in aqueous PBS buffer. The three‐component vaccines that contained the Tetanus Toxoid P2 T‐cell epitope peptide induced strong immune responses, even when administered just in PBS. By activation of the complement‐dependent cytotoxicity (CDC) complex, the antisera induced the killing of tumor cells.     

Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation

Matching of symmetry at interfaces is a fundamental obstacle in molecular assembly. Virus‐like particles (VLPs) are important vaccine platforms against pathogenic threats, including Covid‐19. However, symmetry mismatch can prohibit vaccine nanoassembly. We established an approach for coupling VLPs to diverse antigen symmetries. SpyCatcher003 enabled efficient VLP conjugation and extreme thermal resilience. Many people had pre‐existing antibodies to SpyTag:SpyCatcher but less to the 003 variants. We coupled the computer‐designed VLP not only to monomers (SARS‐CoV‐2) but also to cyclic dimers (Newcastle disease, Lyme disease), trimers (influenza hemagglutinins), and tetramers (influenza neuraminidases). Even an antigen with dihedral symmetry could be displayed. For the global challenge of influenza, SpyTag‐mediated display of trimer and tetramer antigens strongly induced neutralizing antibodies. SpyCatcher003 conjugation enables nanodisplay of diverse symmetries towards generation of potent vaccines.